A patient with CKD stage 4 (eGFR 22 mL/min) requires insulin dose adjustment because:
-
A
The kidneys produce insulin resistance factors that decrease as renal function declines
-
B
Reduced renal insulin clearance prolongs insulin action and increases hypoglycemia risk
-
C
Uremia accelerates insulin degradation requiring higher doses
-
D
Renal impairment reduces carbohydrate absorption, necessitating lower doses